Trescon (532159)

Asset Play

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Current Price₹14.81
Market Cap₹107.35 Cr
P/E Ratio41.59
ROCE-1.93%
ROE3.4%
Dividend Yield0%
Profit Growth284.87%
Debt/Equity
Sales Growth0%
52-Week Range₹6.26 — ₹14.81
SectorRealty
Book Value₹14.63

Strengths

Concerns

AI Analysis

Looking at Trescon, I am reminded that a low price-to-book ratio alone is not enough. At ₹14.81, the share trades at just 1.01 times book value of ₹14.63, so the market is giving the company almost no credit for its stated assets. That is interesting, but also correct in a way: with return on equity of only 3.40% and ROCE at -1.93%, this business earns less than a fixed deposit and destroys capital once you account for the cost of capital. The market cap is ₹107 crore, and the latest quarter shows sales of ₹17 crore and net profit of ₹2 crore. That sounds fine until I remember that sales growth is 0.00%. A 284.87% profit growth on flat sales is a red flag, not a sign of quality. It may be a low base, one-off income, or cost cutting; it is not a repeatable compounding engine. A P/E of 41.59 confirms you are paying a rich multiple for that jump. Even the PEG of 0.15 is meaningless when the 'G' is not sustainable. The Piotroski F-score of 5 out of 9 suggests moderate financial health, but I have no debt figures and no dividend. A business that pays no dividend and cannot deploy capital at high returns would not attract me. Trescon may be an asset play if the land and projects are truly worth book value, but real estate book values can be optimistic. I need to see asset turnover, project execution, and actual cash generation. Given price near book but weak operations, this is not a wonderful business; it is a possible asset situation. If I invest, I want a substantial discount to conservative book value, not 1.01 times. In this market, I would wait or look elsewhere.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer